Does CEO compensation impact patient satisfaction?

Journal of Health Organization and Management
Kunle Akingbola, Herman A van den Berg

Abstract

This study examines the relationship between CEO compensation and patient satisfaction in Ontario, Canada. The purpose of this paper is to determine what impact hospital CEO compensation has on hospital patient satisfaction. The analyses in this study were based on data of 261 CEO-hospital-year observations in a sample of 103 nonprofit hospitals. A number of linear regressions were conducted, with patient satisfaction as the dependent variable and CEO compensation as the independent variable of interest. Controlling variables included hospital size, type of hospital, and frequency of adverse clinical outcomes. CEO compensation does not significantly influence hospital patient satisfaction. Both patient satisfaction and CEO compensation appear to be driven primarily by hospital size. Patient satisfaction decreases, while CEO compensation increases, with the number of acute care beds in a hospital. In addition, CEO compensation does not even appear to moderate the influence of hospital size on patient satisfaction. There are several limitations to this study. First, observations of CEO-hospital-years in which annual nominal CEO compensation was below $100,000 were excluded, as they were not publicly available. Second, this resear...Continue Reading

References

Jan 1, 1991·Health Care Management Review·G H Pink, P Leatt
Jan 1, 1990·Health Affairs·S H AltmanS C Crane
Jan 1, 1993·Health Care Management Review·R E Santerre, J M Thomas
Jul 21, 2001·Journal of Health Economics·C Preyra, G Pink
Mar 11, 2003·Health Services Management Research : an Official Journal of the Association of University Programs in Health Administration·G H PinkI McKillop
Dec 3, 2003·Health Affairs·Donald M BerwickGail R Wilensky
Oct 4, 2005·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Ken AckermanKatherine Swartz
May 3, 2006·Joint Commission Journal on Quality and Patient Safety·Maulik S Joshi, Stephen C Hines
Oct 19, 2006·The International Journal of Health Planning and Management·David W Young, Eduard Ballarin
Nov 3, 2006·The New England Journal of Medicine·Meredith B RosenthalArnold M Epstein
Jul 1, 2008·Journal of Health Economics·Rose Anne Devlin, Sisira Sarma
Jul 17, 2009·Medical Care Research and Review : MCRR·Kristin L ReiterGeorge H Pink
Jan 13, 2010·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Livio Di Matteo
Mar 18, 2010·Health Care Management Review·Koichiro OtaniRichard S Kurz
Dec 15, 2010·The New England Journal of Medicine·Michael E Porter
Dec 16, 2010·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Jeffrey Kramer, Rexford E Santerre
Mar 30, 2012·The New England Journal of Medicine·Ashish K JhaArnold M Epstein
Nov 28, 2012·BMJ Quality & Safety·Ronen RozenblumDavid W Bates

❮ Previous
Next ❯

Citations

Dec 7, 2017·Health Systems·Dinesh R PaiRichard S Brown

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Health Care Quality Assurance
Girish N NadkarniEthan D Fried
Journal of Health Organization and Management
Clive Savory, Joyce Fortune
© 2022 Meta ULC. All rights reserved